Author:
Tiberi Simon,Lampejo Temi,Zumla Alimuddin
Publisher
Springer International Publishing
Reference39 articles.
1. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. Accessed 10 Apr 2019.
2. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 2020; ISBN 978-92-4-001866-2 (electronic version) ISBN 978-92-4-001867-9 (print version) © World Health Organization 2021.
3. Medical Research Council. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. BMJ. 1948;2:769–82.
4. Global tuberculosis report 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. Available on https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?ua=1. Accessed 15 Mar 2019.
5. Ahmad N, Ahuja SD, Akkerman OW, Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, et al. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet. 2018;392:821–34.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献